What is precision medicine and how is this changing the future of cancer treatment?
Precision medicine is an innovative approach that involves tailoring medical treatment to suit the specific needs of a patient. An individual’s genetics, environment and lifestyle are taken into consideration to understand what treatment will work best for them. This approach is known for enhancing overall health outcomes significantly, particularly for cancer patients. While precision medicine is useful for treating all sorts of diseases, oncology is one of the fields that has benefitted the most because of its size, disease heterogeneity and high number of approved biomarkers. For more info: https://www.zs.com/insights/pharmaceutical-trends-2025-outlook-ai-supplychain-and-beyond
Precision medicine is an innovative approach that involves tailoring medical treatment to suit the specific needs of a patient. An individual’s genetics, environment and lifestyle are taken into consideration to understand what treatment will work best for them. This approach is known for enhancing overall health outcomes significantly, particularly for cancer patients. While precision medicine is useful for treating all sorts of diseases, oncology is one of the fields that has benefitted the most because of its size, disease heterogeneity and high number of approved biomarkers. For more info: https://www.zs.com/insights/pharmaceutical-trends-2025-outlook-ai-supplychain-and-beyond
What is precision medicine and how is this changing the future of cancer treatment?
Precision medicine is an innovative approach that involves tailoring medical treatment to suit the specific needs of a patient. An individual’s genetics, environment and lifestyle are taken into consideration to understand what treatment will work best for them. This approach is known for enhancing overall health outcomes significantly, particularly for cancer patients. While precision medicine is useful for treating all sorts of diseases, oncology is one of the fields that has benefitted the most because of its size, disease heterogeneity and high number of approved biomarkers. For more info: https://www.zs.com/insights/pharmaceutical-trends-2025-outlook-ai-supplychain-and-beyond
0 Commentarii
0 Distribuiri
88 Views
0 previzualizare